Mcf Advisors LLC Gilead Sciences, Inc. Transaction History

Mcf Advisors LLC

$1.42 Billion
Q3 2024

A detailed history of Mcf Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mcf Advisors LLC holds 4,668 shares of GILD stock, worth $412,651. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,668

Previous 4,754 1.81%

Holding current value

$412,651

Previous $326,000 19.94%

% of portfolio

0.03%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$66.59 - $83.99 $5,726 - $7,223	-86 Reduced 1.81%	4,668 $391,000
Q2 2024 Aug 05, 2024	SELL	$63.15 - $72.88 $163,811 - $189,050	-2,594 Reduced 35.3%	4,754 $326,000
Q1 2024 Apr 16, 2024	BUY	$71.58 - $87.29 $10,880 - $13,268	152 Added 2.11%	7,348 $538,000
Q4 2023 Feb 01, 2024	BUY	$73.27 - $83.09 $41,983 - $47,610	573 Added 8.65%	7,196 $582,000
Q3 2023 Oct 19, 2023	BUY	$73.94 - $80.67 $31,350 - $34,204	424 Added 6.84%	6,623 $496,000
Q2 2023 Jul 24, 2023	SELL	$76.01 - $86.7 $18,850 - $21,501	-248 Reduced 3.85%	6,199 $477,000
Q1 2023 Apr 18, 2023	BUY	$77.31 - $88.08 $15,462 - $17,616	200 Added 3.2%	6,447 $534,000
Q4 2022 Jan 31, 2023	BUY	$62.32 - $89.47 $103,700 - $148,878	1,664 Added 36.31%	6,247 $536,000
Q3 2022 Nov 09, 2022	BUY	$59.54 - $68.01 $52,514 - $59,984	882 Added 23.83%	4,583 $283,000
Q2 2022 Aug 11, 2022	SELL	$57.72 - $65.01 $26,089 - $29,384	-452 Reduced 10.88%	3,701 $229,000
Q1 2022 May 05, 2022	BUY	$57.92 - $72.58 $240,541 - $301,424	4,153 New	4,153 $246,000
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $194,056 - $220,257	-2,991 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $77,505 - $83,619	1,145 Added 62.03%	2,991 $209,000
Q2 2021 Aug 10, 2021	BUY	$63.47 - $69.35 $97,680 - $106,729	1,539 Added 501.3%	1,846 $127,000
Q1 2021 May 13, 2021	BUY	$60.0 - $68.46 $18,420 - $21,017	307 New	307 $20,000

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcf Advisors LLC with notifications on news.

Account